X

Adverum Biotechnologies, inc (ADVM) Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMD, Reports Recent Business Progress and Fourth Quarter 2020 Financial Results

Adverum Biotechnologies, inc (NASDAQ: ADVM) Q4 2020 Earnings Conference

Newsdesk: